These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21265876)

  • 21. Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations.
    Soriano A; Vicente J; Carcas C; Gonzalez-Andrade F; Arenaz I; Martinez-Jarreta B; Fanlo A; Mayayo E; Sinués B
    Fundam Clin Pharmacol; 2011 Oct; 25(5):627-32. PubMed ID: 21410749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
    Paschke T; Riefler M; Schuler-Metz A; Wolz L; Scherer G; McBride CM; Bepler G
    Toxicology; 2001 Nov; 168(3):259-68. PubMed ID: 11684323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.
    Tsukino H; Kuroda Y; Qiu D; Nakao H; Imai H; Katoh T
    Int J Cancer; 2002 Aug; 100(4):425-8. PubMed ID: 12115524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel human CYP2A6 alleles confound gene deletion analysis.
    Nakajima M; Yoshida R; Fukami T; McLeod HL; Yokoi T
    FEBS Lett; 2004 Jul; 569(1-3):75-81. PubMed ID: 15225612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
    Kwon JT; Nakajima M; Chai S; Yom YK; Kim HK; Yamazaki H; Sohn DR; Yamamoto T; Kuroiwa Y; Yokoi T
    Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of genes coding to alcohol-metabolizing enzymes in western Mexicans: association of CYP2E1*c2/CYP2E1*5B allele with cirrhosis and liver function.
    García-Bañuelos J; Panduro A; Gordillo-Bastidas D; Gordillo-Bastidas E; Muñoz-Valle JF; Gurrola-Díaz CM; Sánchez-Enríquez S; Ruiz-Madrigal B; Bastidas-Ramírez BE
    Alcohol Clin Exp Res; 2012 Mar; 36(3):425-31. PubMed ID: 21895718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
    Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.
    Fang WJ; Mou HB; Jin DZ; Zheng YL; Zhao P; Mao CY; Peng L; Huang MZ; Xu N
    Oncol Rep; 2012 May; 27(5):1606-10. PubMed ID: 22322240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.
    Semiz S; Dujić T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Mlinar B; Marc J; Causević A
    Med Glas (Zenica); 2011 Feb; 8(1):84-9. PubMed ID: 21263403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
    Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
    Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
    Ulusoy G; Arinç E; Adali O
    Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
    Sailaja K; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations.
    Shahriary GM; Galehdari H; Jalali A; Zanganeh F; Alavi SM; Aghanoori MR
    Asian Pac J Cancer Prev; 2012; 13(12):6505-10. PubMed ID: 23464483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variability in CYP3A5 and its possible consequences.
    Xie HG; Wood AJ; Kim RB; Stein CM; Wilkinson GR
    Pharmacogenomics; 2004 Apr; 5(3):243-72. PubMed ID: 15102541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    Cancer Lett; 2006 Sep; 241(1):135-41. PubMed ID: 16377082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
    Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
    Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
    Fohner A; Muzquiz LI; Austin MA; Gaedigk A; Gordon A; Thornton T; Rieder MJ; Pershouse MA; Putnam EA; Howlett K; Beatty P; Thummel KE; Woodahl EL
    Pharmacogenet Genomics; 2013 Aug; 23(8):403-14. PubMed ID: 23778323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
    Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
    Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Lim SYM; Alshagga MA; Alshawsh MA; Ong CE; Pan Y
    Drug Metab Pers Ther; 2021 Aug; 37(1):55-67. PubMed ID: 35146975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.